Navigation Links
Agarose-High-Res™, Separation <500 bp

ProductsAgarose-High-Res™, Separation <500 bp
Company USB Corporation
Item Agarose-High-Res™, Separation <500 bp
Features 
Description Ultrapure
MB Grade
PRODUCT SPECIFICATIONS
Form: Granular, free flowing powder
EEO(-mr): less than or equal to 0.12
Gel Point (3%): less than or equal to 31C
Remelt Point (3%): less than or equal to 76C
Gel Strength (3%): greater than or equal to 500 gm/cm2
Gel Strength (5%): greater than or equal to 1000 gm/cm2
Moisture: less than or equal to 7%
Turbidity (3%): less than or equal to 75 Np
Residue on Ignition: less than or equal to 0.3%
Sulfate (SO4): less than or equal to 0.11%
DNase: Passes test
RNase: Passes test
Separation Guidelines:
Range of separation in 1X TAE:
3.0%: 500 - 80 bp
4.0%: 300 - 30 bp
5.0%: 200 - 10 bp

Applications:

*Highly resolved separation of DNA or RNA fragments less than or equal to 500 bp.
*PCR analysis.

Note:
Before use, chill gels at 4C for 20 hours to achieve best resolution.
CAS # 9012-36-6
Info USB Corporation
Customer Service: (800) 321-9322
Web site: http://www.usbweb.com

Related medicine products :

1. Elutra Cell Separation System
2. Agarose for the Separation of GeneAmp® PCR Products
3. Agarose - Hi-Res™, Separation < 1000 bp
4. Agarose - Separation >500 bp Genetic Performance Certified™
5. PhastSystem Separation-Control and Development Units 120 VAC
6. PhastSystem Separation-Control and Development Units 220 VAC
System, English (Continental cord), 230 VAC....
Micro-mini fiber optic light....
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
International version of the Twin Beam, it is BSI-, IEC-, CE- approved....
Medicine Products:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: